Michael Muzoora, MD
Pulmonary Disease · Owensboro, KYNPI 1629237458
Payments from drug & device makers
Across 449 payments — averaging $39.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Penumbra, Inc.$3K
- GSK$2K
- AstraZeneca$1K
- Actelion Pharmaceuticals US, Inc.$817
- Boehringer Ingelheim$539
- plus $4K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $6,852 |
| Penumbra, Inc. | 9 | $2,821 |
| GSK | 110 | $1,528 |
| AstraZeneca | 55 | $1,479 |
| Actelion Pharmaceuticals US, Inc. | 32 | $817 |
| Boehringer Ingelheim | 31 | $539 |
| Sunovion Pharmaceuticals Inc. | 30 | $401 |
| Insmed, Inc. | 25 | $387 |
| Sanofi | 16 | $333 |
| Olympus America Inc. | 5 | $321 |
| Gilead | 14 | $222 |
| Electromed, Inc. | 14 | $220 |
| Regeneron Healthcare Solutions, Inc. | 13 | $219 |
| Grifols USA, LLC | 14 | $211 |
| Mylan Specialty L.p. | 12 | $183 |
| United Therapeutics Corporation | 6 | $152 |
| Amgen | 6 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Livanova USA, Inc. | 1 | $91 |
| Harmony Biosciences LLC | 3 | $89 |
| Genentech USA, Inc. | 7 | $87 |
| Merck | 6 | $84 |
| Philips North America LLC | 5 | $80 |
| Teva Pharmaceuticals USA, Inc. | 6 | $79 |
| Novartis | 3 | $73 |
| Inari Medical, Inc. | 1 | $72 |
| CSL Behring | 2 | $42 |
| Baxter Healthcare | 2 | $40 |
| Viatris Specialty LLC | 2 | $34 |
| Abiomed | 1 | $30 |
| Mayne Pharma Commercial LLC | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Veran Medical Technologies, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
| AbbVie | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
| Resmed Corp | 1 | $14 |
| Pfizer | 1 | $11 |
How this compares
$17,858 in reported general payments places this provider in the 85th percentile of 226 pulmonary disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Owensboro
- Rejmon DedajOwensboro$14K
- Berhanemeskel NesketaOwensboro$14K
- Thomas WaringOwensboro$13K
- John McConnellLouisville$3.5M
- Girish NairLexington$852K
- Sally SulimanLouisville$472K
- Mohamed SaadLouisville$440K
- David WinslowLouisville$431K
- Firas KouraGeorgetown$423K
- Erica GregonisRichmond$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.